KEY PRODUCTS
Qingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.
01 1Sichuan Qingmu Pharmaceutical
01 1METHYLENE BLUE
01 1China
01 1Active
01 1Complete
Qingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.
GDUFA
DMF Review : Complete
Rev. Date : 2024-05-01
Pay. Date : 2024-04-19
DMF Number : 39341
Submission : 2024-04-15
Status : Active
Type : II
20
Sichuan Qingmu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for Qingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.
One of their notable products is METHYLENE BLUE, with a corresponding US DMF Number 39341.
Remarkably, this DMF maintains an Active status since its submission on April 15, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 01, 2024, and payment made on April 19, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
